REGULATED INDUSTRIES END USER: On the Rise
November 1, 2007
U.S. medical and dental adhesives & sealants
demand to reach $1.8 billion in 2011.
U.S. demand for medical and dental adhesives and sealants
is forecast to rise 7.6% per year to $1.8 billion in 2011. Much of this growth
can be attributed to the aging U.S.
population, since older individuals are more likely to require surgical and
dental procedures than other age groups. Advances will also depend on
continuing new-product development and increasing acceptance of these materials
in surgical and consumer settings. These and other trends are presented in Medical
& Dental Adhesives & Sealants, a new study from The
Freedonia Group Inc., a Cleveland-based industry research firm.
With the exception of joint replacements and most dental applications, medical applications for adhesives and sealants are relatively new; thus, many markets are experiencing fast growth off a small base. Opportunities are expected for cyanoacrylate, polyethylene glycol, and various plasma and protein types. Cyanoacrylate adhesives are projected to find greater use in external tissue-bonding applications. Rapid gains should result from the commercialization of several products presently in development, including cyanoacrylates for internal applications.
Medical applications will achieve more rapid growth than dental applications through 2011. In internal medical applications, adhesives and sealants will experience the best growth in situations where the tissue involved is affected by pressure caused by blood (e.g., capillaries, veins or arteries), air (e.g., the lungs), solids (e.g., the gastrointestinal system) or fluids (e.g., the dural membrane in the cranial region, the bladder or the spinal cord). In external medical applications, adhesives and sealants will find increased opportunities in external tissue bonding, particularly on low-tension wounds.
Dental applications will post annual growth of 4.1% through 2011. Good opportunities still exist, especially in newer products. For example, pit and fissure sealants will register strong gains due to their use in cavity prevention. Products such as denture adhesives, restorative adhesives and luting cements will see limited gains through 2011, primarily due to overall improved dental health in the U.S. population.
For more information, contact Corinne Gangloff, The Freedonia Group Inc., 767 Beta Drive, Cleveland, OH 44143-2326; phone (440) 684-9600; fax (440) 646-0484; e-mail pr@freedoniagroup.com; or visit www.freedoniagroup.com.
Table.
With the exception of joint replacements and most dental applications, medical applications for adhesives and sealants are relatively new; thus, many markets are experiencing fast growth off a small base. Opportunities are expected for cyanoacrylate, polyethylene glycol, and various plasma and protein types. Cyanoacrylate adhesives are projected to find greater use in external tissue-bonding applications. Rapid gains should result from the commercialization of several products presently in development, including cyanoacrylates for internal applications.
Medical applications will achieve more rapid growth than dental applications through 2011. In internal medical applications, adhesives and sealants will experience the best growth in situations where the tissue involved is affected by pressure caused by blood (e.g., capillaries, veins or arteries), air (e.g., the lungs), solids (e.g., the gastrointestinal system) or fluids (e.g., the dural membrane in the cranial region, the bladder or the spinal cord). In external medical applications, adhesives and sealants will find increased opportunities in external tissue bonding, particularly on low-tension wounds.
Dental applications will post annual growth of 4.1% through 2011. Good opportunities still exist, especially in newer products. For example, pit and fissure sealants will register strong gains due to their use in cavity prevention. Products such as denture adhesives, restorative adhesives and luting cements will see limited gains through 2011, primarily due to overall improved dental health in the U.S. population.
For more information, contact Corinne Gangloff, The Freedonia Group Inc., 767 Beta Drive, Cleveland, OH 44143-2326; phone (440) 684-9600; fax (440) 646-0484; e-mail pr@freedoniagroup.com; or visit www.freedoniagroup.com.